A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

BenevolentAI

BenevolentAI uses artificial intelligence to mine and analyse biomedical information, from clinical trails data to academic papers.

Benevolent AI can also use the predictive power of its AI algorithm to design new molecules, extracting new hypothesis based on a knowledge graph composed of over a billion relationships between genes, targets, diseases, proteins and drugs. “When the periodic table of the elements was generated, there were gaps in that table where you know elements had to exist, but they hadn't been discovered,” Hunter says. “We use our knowledge graph like that: what relationship should be present but are not yet known?"

Founded
2013
Status
Private company
Geography
United Kingdom based
Funding
$292 M

Posts Mentioning This Company

Video gallery
Biopharma Insights
Biopharma Insights

Products

The Benevolent Platform

Read more

Services

No services posted yet